NasdaqGS:ASNDBiotechs
Is It Time To Reassess Ascendis Pharma (ASND) After Its Strong Multi‑Year Share Price Run?
If you are wondering whether Ascendis Pharma's share price still offers value after a strong run, the key is to look closely at what the current valuation actually reflects.
The stock last closed at US$228.73, with returns of 6.1% over 7 days, a 2.0% decline over 30 days, 7.2% year to date, 51.0% over 1 year, 220.2% over 3 years and 73.7% over 5 years.
Recent price moves have come alongside ongoing attention on Ascendis Pharma's pipeline progress and funding position, as investors reassess...